text_1: Tonic signaling from the scFv prevents constitutive stimulation.
text_2: It remains unknown whether the impressive effects of CD19 CARs relate to greater susceptibility of hematologic malignancies to CAR therapies, or superior functionality of the CD19 CAR itself.